Conference abstract
Evaluation of ZOSTAVAX? via the intradermal route using the MicronJet?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
H ere we report the results of intradermal vaccination studies that were performed with an attenuated virus (varicella; ZOSTAVAX?). Intradermal vaccination using the MicronJet? by Nanopass Technologies was compared to the current route of administration (subcutaneous). It was demonstrated with ZOSTAVAX? that doses of 1/3 rd and 1/10 th , the full dose elicited both antibody and T-cell responses that were equivalent to a full dose delivered subcutaneously. A full dose of ZOSTAVAX? administered intradermally resulted in a higher overall antibody titer when compared to the subcutaneous route.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Brian K Meyer”
- BylineArticles whose byline prints “Chan Beals”
- BylineArticles whose byline prints “Yotam Levin”
- BylineArticles whose byline prints “Robert K Evans”